ATG16L1 T300A Shows Strong Associations With Disease Subgroups in a Large Australian IBD Population: Further Support for Significant Disease Heterogeneity
about
Genetic Influences on the Development of Fibrosis in Crohn's DiseaseMolecular reclassification of Crohn's disease: a cautionary note on population stratificationGenetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityThe polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians.Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel diseasePolymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel diseaseGenotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms.Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach.Antimicrobial peptides and gut microbiota in homeostasis and pathology.Association between variants of the autophagy related gene--IRGM and susceptibility to Crohn's disease and ulcerative colitis: a meta-analysis.Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.Influence of Crohn's disease risk alleles and smoking on disease location.Genome-wide association studies--a summary for the clinical gastroenterologist.Links between autophagy, innate immunity, inflammation and Crohn's diseaseInhibition of Autophagic Degradation Process Contributes to Claudin-2 Expression Increase and Epithelial Tight Junction Dysfunction in TNF-α Treated Cell Monolayers.ER stress and the unfolded protein response in intestinal inflammation.Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer.Innate antimicrobial immunity in inflammatory bowel diseases.Genetics of childhood-onset inflammatory bowel disease.Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis.The role of autophagy in Crohn's disease.Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.ATG16L1 and IL23R variants and genetic susceptibility to crohn's disease: mode of inheritance based on meta-analysis of genetic association studies.Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).The impact of smoking in Crohn's disease: no smoke without fire.Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.MicroRNAs: how many in inflammatory bowel disease?Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study.T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis.Predictors of Outcome in Ulcerative Colitis.Role of defective autophagia and the intestinal flora in Crohn disease.Non-Jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency.Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II).KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population.Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease.
P2860
Q26745889-5360AAA2-E7A1-4CCE-B0E8-B2E2B986069FQ28673414-D769A6BB-F275-4403-850D-4636821719D2Q30251388-7F8D7121-5E0D-40BF-9EBF-E9CA5377E920Q33590163-9948D8B2-74F2-4B63-88DF-6BFE7A119478Q33708244-7128D6F7-324B-43A4-83E2-0BD90DED3C23Q33817102-CA972165-8F0B-41B3-AC0E-9E6FC6ECFB9BQ33819478-0F179629-3E1B-4A30-9847-88BE69052B0DQ33916737-A5DDD858-7F55-40EC-8A28-F4E6293791C1Q34174340-1811C535-37A5-47EB-96F1-37E73CFA73A4Q34487187-6EA76DCA-E040-4207-8AC7-F7F41976BA6BQ34540483-D5060A67-3DAB-4E73-8165-1F1F5F572BD7Q34984586-ABF5B32D-DAEC-42FF-93B4-9180C45248F2Q34987870-25879071-6400-4125-B057-AC471D70F215Q35043154-F3DC4B5F-950A-4D3D-98F5-B524AAD79E3DQ35876578-6734DE1E-35E4-4D46-91AF-7774D2D7AF33Q36111890-A35F5A36-6C96-453B-818A-F6B13BC884E0Q37422991-1543033E-E983-44B5-93CA-FACFE8C50FE4Q37604740-AE808FE2-2576-4CAD-AB13-371646902F3AQ37631619-3D8E47A1-086D-494B-AE27-0EACAAC7676EQ37719188-6DC6CA57-0FCA-4DA5-8767-6B15357663C9Q37764367-7431B797-0134-4288-B4D2-CF74275A56E7Q37786633-2C85F932-8A6F-4AE2-AEB5-5B460A23D3DCQ37788639-EA2C64D0-6E59-4A96-9038-CEAF800EC3BEQ37847109-EE5FFA43-2F0D-4731-919A-6C785D4945C7Q38202872-800C6C63-E202-427A-83CB-C1374E5AA31BQ38365426-AE2523C8-5F11-46AE-A141-707338B6BEE9Q38367539-A7E57AD3-C4CB-4AFC-90D9-AB1D16C55282Q38394640-D8C350A0-6273-4789-A71D-170878AE949BQ38609224-3EC22437-4D0F-42F1-86E4-4E8FA28B13FDQ38785010-9178586B-52C0-4A8C-A74B-6D175AA6BF8DQ38823581-D8549B38-9451-4334-B62F-6226FFBD591FQ38976561-E7C8282E-53AE-4A73-8858-2FE51526D759Q39440514-72827B4F-5613-4A19-87CB-B30BF6624C5BQ39638373-976F980A-67E7-4301-B895-020E754BE705Q40733901-6211E971-EB59-4711-938C-6AA89F10C41BQ42702217-1A5D83F7-855D-4F19-8C68-97C7479E6EC2Q43635405-0751B1CA-403A-46F3-A3BB-35AD01F0F0BEQ43829519-633B2D6F-1BC8-4C3D-B586-446689B9E3C3Q44531487-5D4A6122-09A3-4A8F-919A-2525AE8DC324Q45159389-2B6FD59B-DE1D-4AE0-8EF9-E7BDAFE837F2
P2860
ATG16L1 T300A Shows Strong Associations With Disease Subgroups in a Large Australian IBD Population: Further Support for Significant Disease Heterogeneity
description
article
@en
im Juli 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2008
@uk
name
ATG16L1 T300A Shows Strong Ass ...... nificant Disease Heterogeneity
@en
ATG16L1 T300A Shows Strong Ass ...... nificant Disease Heterogeneity
@nl
type
label
ATG16L1 T300A Shows Strong Ass ...... nificant Disease Heterogeneity
@en
ATG16L1 T300A Shows Strong Ass ...... nificant Disease Heterogeneity
@nl
prefLabel
ATG16L1 T300A Shows Strong Ass ...... nificant Disease Heterogeneity
@en
ATG16L1 T300A Shows Strong Ass ...... nificant Disease Heterogeneity
@nl
P2093
P2860
P50
P1476
ATG16L1 T300A shows strong ass ...... nificant disease heterogeneity
@en
P2093
Elizabeth V Fowler
Graham L Radford-Smith
Juleen A Cavanaugh
Lisa A Simms
Nicholas K Hayward
Timothy H Florin
Zhen Zhen Zhao
P2860
P304
P356
10.1111/J.1572-0241.2008.02023.X
P407
P577
2008-07-30T00:00:00Z